<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for SNY</title>
    <link />
    <description>Headlines for Sanofi (ADR)</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>5 Stocks Underperforming Today In The Drugs Industry</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11928285/1/5-stocks-underperforming-today-in-the-drugs-industry.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Mon, 20 May 2013 13:04:00 GMT</pubDate>
    </item>
    <item>
      <title>Catalyst Pharmaceutical's CPP-115 May Be Big Pipeline In Just One Little Pill</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1447111-catalyst-pharmaceutical-s-cpp-115-may-be-big-pipeline-in-just-one-little-pill.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 20 May 2013 11:30:31 GMT</pubDate>
    </item>
    <item>
      <title>1 Great Dividend You Can Buy Right Now</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/19/1-great-dividend-you-can-buy-right-now-31/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 19 May 2013 16:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Started</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/19/multiple-sclerosis-hemophilia-this-biotechs-just-g/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sun, 19 May 2013 14:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Will ASCO Unlock Big Value in This Cancer Drug Class?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/18/will-asco-unlock-big-value-in-this-cancer-drug-cla/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 18 May 2013 14:30:00 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/18/this-week-in-biotech-27/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 18 May 2013 13:45:00 GMT</pubDate>
    </item>
    <item>
      <title>1 Giant Leap for MannKind</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/18/1-giant-leap-for-mannkind/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 18 May 2013 12:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Sanofi Could Exit Toulouse Site in 5 Years</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130517-000490&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Fri, 17 May 2013 15:18:59 GMT</pubDate>
    </item>
    <item>
      <title>Sanofi Reports Positive Results on Study on Inhibitor in Myelofibrosis</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130517-000076&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Fri, 17 May 2013 01:23:59 GMT</pubDate>
    </item>
    <item>
      <title>Presentation Pandemonium = 30% Pop</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/16/presentation-pandemonium-30-pop/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 16 May 2013 19:13:00 GMT</pubDate>
    </item>
    <item>
      <title>Why Warren Buffett Sees Opportunity In Europe</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1440321-why-warren-buffett-sees-opportunity-in-europe.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 16 May 2013 11:49:11 GMT</pubDate>
    </item>
    <item>
      <title>Sanofi and Regeneron's Latest Partnership</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/15/sanofi-and-regenerons-latest-partnership-4/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Wed, 15 May 2013 21:13:00 GMT</pubDate>
    </item>
    <item>
      <title>Sanofi/REGN Commence Enrollment - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99496/sanofi-regn-commence-enrollment.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 15 May 2013 17:30:01 GMT</pubDate>
    </item>
    <item>
      <title>LabStyle Innovations - Glucose Monitoring For The Mobile Age</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1436791-labstyle-innovations-glucose-monitoring-for-the-mobile-age.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 15 May 2013 12:24:04 GMT</pubDate>
    </item>
    <item>
      <title>FDA Accepts Merck BLA - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/99443/fda-accepts-merck-bla.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 15 May 2013 11:40:01 GMT</pubDate>
    </item>
    <item>
      <title>New Stock Coverage: LinkedIn Will Have a Hard Job Maintaining Gains</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/trading-and-investing/stocks/articles/new-stock-coverage253a-linkedin-will-have/5/15/2013/id/49827.aspx?source=itxwebtxt0000015</link>
      <author>Minyanville</author>
      <pubDate>Wed, 15 May 2013 09:20:00 GMT</pubDate>
    </item>
    <item>
      <title>Sanofi, Regeneron Announce Patient Enrollment in Two Phase 3 Sarilumab Trials for Rheumatoid Arthrit</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/earnings/13/05/3590685/sanofi-regeneron-announce-patient-enrollment-in-two-phase-3-sarilumab-tr.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Wed, 15 May 2013 05:55:06 GMT</pubDate>
    </item>
    <item>
      <title>Sanofi Smear Campaign to Limit Plavix Competition</title>
      <link>http://www.fool.com/news/xt/ycharts/ycharts.com/analysis/story/sanofi_smear_campaign_to_limit_plavix_competition.aspx?source=itxwebtxt0000015</link>
      <author>YCharts</author>
      <pubDate>Tue, 14 May 2013 19:59:25 GMT</pubDate>
    </item>
    <item>
      <title>French Antitrust Authority Fines Sanofi EUR40.6 Million</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130514-000134&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Tue, 14 May 2013 05:50:59 GMT</pubDate>
    </item>
    <item>
      <title>10 Hot Healthcare Dogs Probe 6% To 38.2% Gains In April</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1430691-10-hot-healthcare-dogs-probe-6-to-38-2-gains-in-april.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 13 May 2013 14:43:19 GMT</pubDate>
    </item>
  </channel>
</rss>
